• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性骨髓瘤患者报告认知功能的纵向分析。

Longitudinal Analysis of Patient-Reported Cognitive Function in Multiple Myeloma.

机构信息

Northeast Ohio Medical University, Rootstown, OH.

Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.

出版信息

Clin Lymphoma Myeloma Leuk. 2022 Dec;22(12):920-927. doi: 10.1016/j.clml.2022.08.002. Epub 2022 Aug 15.

DOI:10.1016/j.clml.2022.08.002
PMID:36085276
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9691560/
Abstract

BACKGROUND

Cancer-related cognitive impairment (CRCI) has been largely unstudied in patients with multiple myeloma (MM). This study describes patient-reported cognition over time and patient factors associated with adverse cognitive outcomes in MM.

METHODS

Participants enrolled in a registry in which they completed a geriatric assessment at study entry, and 3 & 6 months after entry. Cognitive function was assessed using the EORTC QLQ-C30 Cognitive Function subscale, with CRCI defined as scores < 75. Generalized estimating equation (GEE) models were used to fit longitudinal models to investigate differences by group and differences in changes over time by group, with adjustment for time since diagnosis.

RESULTS

One hundred and four adults with MM had mean age of 67 years and 30% identified as Black. Patient-reported CRCI was present in 18% of participants at enrollment, 21% at 3 months, and 30% at 6 months. Worse cognitive function was reported in those with impairments in physical function (P = .002), IADLs (P = .02), and performance status (P = .04), as well as in those who were prefrail/frail (P = .02) and depressed (P = .049). Greater cognitive decline over time was observed in patients without CRCI at enrollment (P < .0001) and those with lower levels of education (P = .04).

CONCLUSION

This is one of the first studies to describe longitudinal changes in patient-reported cognition in patients with MM. Several potentially intervenable factors, including physical function impairment and depression, were associated with worse cognition at study entry, but only baseline CRCI status and education level were predictive of future decline.

摘要

背景

多发性骨髓瘤(MM)患者的癌症相关认知障碍(CRCI)研究甚少。本研究描述了 MM 患者随时间推移的认知变化以及与认知不良结局相关的患者因素。

方法

参与者在注册中心登记,在登记时以及登记后 3 个月和 6 个月进行了老年评估。使用 EORTC QLQ-C30 认知功能子量表评估认知功能,CRCI 定义为得分<75。使用广义估计方程(GEE)模型拟合纵向模型,以研究组间差异和组间随时间变化的差异,并根据诊断后时间进行调整。

结果

104 名 MM 成年患者的平均年龄为 67 岁,30%的患者为黑人。18%的参与者在登记时报告存在认知障碍,3 个月时为 21%,6 个月时为 30%。身体功能(P=0.002)、IADLs(P=0.02)和表现状态(P=0.04)受损、衰弱/脆弱(P=0.02)和抑郁(P=0.049)的患者报告的认知功能更差。在登记时无 CRCI 的患者(P<0.0001)和受教育程度较低的患者(P=0.04)随时间观察到更大的认知下降。

结论

这是首批描述 MM 患者报告认知随时间变化的研究之一。一些潜在的可干预因素,包括身体功能障碍和抑郁,与研究开始时的认知障碍有关,但只有基线 CRCI 状态和教育程度与未来的认知下降有关。

相似文献

1
Longitudinal Analysis of Patient-Reported Cognitive Function in Multiple Myeloma.多发性骨髓瘤患者报告认知功能的纵向分析。
Clin Lymphoma Myeloma Leuk. 2022 Dec;22(12):920-927. doi: 10.1016/j.clml.2022.08.002. Epub 2022 Aug 15.
2
Predictors of baseline cancer-related cognitive impairment in cancer patients scheduled for a curative treatment.计划接受根治性治疗的癌症患者基线癌症相关认知障碍的预测因素。
Psychooncology. 2017 May;26(5):632-639. doi: 10.1002/pon.4200. Epub 2016 Aug 1.
3
The Effect of Exercise on Cancer-Related Cognitive Impairment and Applications for Physical Therapy: Systematic Review of Randomized Controlled Trials.运动对癌症相关认知障碍的影响及物理治疗的应用:随机对照试验的系统评价。
Phys Ther. 2020 Mar 10;100(3):523-542. doi: 10.1093/ptj/pzz090.
4
Self-reported cognitive outcomes among adolescent and young adult patients with noncentral nervous system cancers.青少年和年轻成年非中枢神经系统癌症患者的自我报告认知结果。
Psychooncology. 2020 Aug;29(8):1355-1362. doi: 10.1002/pon.5456. Epub 2020 Jul 9.
5
Association of IMWG frailty score with health-related quality of life profile of patients with relapsed refractory multiple myeloma in Italy and the UK: a GIMEMA, multicentre, cross-sectional study.意大利和英国 GIMEMA 多中心、横断面研究:IMWG 虚弱评分与复发/难治性多发性骨髓瘤患者健康相关生活质量特征的相关性。
Lancet Healthy Longev. 2022 Sep;3(9):e628-e635. doi: 10.1016/S2666-7568(22)00172-6.
6
Cognitive function in Prefrail and frail community-dwelling older adults in China.中国社区居住的衰弱前期和衰弱老年人的认知功能。
BMC Geriatr. 2019 Feb 27;19(1):53. doi: 10.1186/s12877-019-1056-8.
7
An Evaluation of the Multifactorial Model of Cancer-Related Cognitive Impairment.癌症相关认知障碍的多因素模型评估。
Nurs Res. 2023;72(4):272-280. doi: 10.1097/NNR.0000000000000660. Epub 2023 Apr 24.
8
Self-reported chemotherapy-related cognitive impairment compared with cognitive complaints following menopause.与绝经后认知抱怨相比,自我报告的化疗相关认知障碍。
Psychooncology. 2018 Sep;27(9):2198-2205. doi: 10.1002/pon.4796. Epub 2018 Jul 13.
9
Chemotherapy-related cognitive impairment in older patients with cancer.癌症老年患者的化疗相关认知障碍。
J Geriatr Oncol. 2016 Jul;7(4):270-80. doi: 10.1016/j.jgo.2016.04.008. Epub 2016 Jul 5.
10
Association between patient-reported hearing and visual impairments and functional, psychological, and cognitive status among older adults with cancer.癌症老年患者中报告的听力和视力障碍与功能、心理和认知状况之间的关联。
Cancer. 2018 Aug 1;124(15):3249-3256. doi: 10.1002/cncr.31540. Epub 2018 May 24.

引用本文的文献

1
Health-related quality of life with daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible patients with newly diagnosed multiple myeloma: analysis of the phase 3 OCTANS study.达雷妥尤单抗、硼替佐米、美法仑和泼尼松联合用药与单独使用硼替佐米、美法仑和泼尼松治疗新诊断的不适于移植的多发性骨髓瘤患者的健康相关生活质量:3期OCTANS研究分析
Ann Hematol. 2025 May 23. doi: 10.1007/s00277-025-06303-3.
2
Hematological Malignancies in Older Patients: Focus on the Potential Role of a Geriatric Assessment Management.老年患者的血液系统恶性肿瘤:聚焦老年评估管理的潜在作用
Diagnostics (Basel). 2024 Jun 29;14(13):1390. doi: 10.3390/diagnostics14131390.

本文引用的文献

1
Prevalence and clinical correlates of cognitive impairment in adults with plasma cell disorders.浆细胞疾病成人认知障碍的患病率及临床相关性。
J Geriatr Oncol. 2022 Sep;13(7):987-996. doi: 10.1016/j.jgo.2022.04.010. Epub 2022 Apr 26.
2
Evaluating the association of frailty with communication about aging-related concerns between older patients with advanced cancer and their oncologists.评估虚弱与老年晚期癌症患者及其肿瘤医生之间有关衰老相关问题沟通的关系。
Cancer. 2022 Mar 1;128(5):1101-1109. doi: 10.1002/cncr.34010. Epub 2021 Nov 11.
3
Cognitive skill training improves memory, function, and use of cognitive strategies in cancer survivors.认知技能训练可改善癌症幸存者的记忆力、功能和认知策略的使用。
Support Care Cancer. 2022 Jan;30(1):711-720. doi: 10.1007/s00520-021-06453-w. Epub 2021 Aug 9.
4
Relationship between cognitive functioning and frailty in older breast cancer survivors.老年乳腺癌幸存者认知功能与虚弱的关系。
J Geriatr Oncol. 2022 Jan;13(1):27-32. doi: 10.1016/j.jgo.2021.07.011. Epub 2021 Aug 5.
5
Health-related quality of life in patients with relapsed or refractory multiple myeloma: treatment with daratumumab, lenalidomide, and dexamethasone in the phase 3 POLLUX trial.在复发或难治性多发性骨髓瘤患者中的健康相关生活质量:在 3 期 POLLUX 试验中用达雷妥尤单抗、来那度胺和地塞米松治疗。
Br J Haematol. 2021 Jul;194(1):132-139. doi: 10.1111/bjh.17435. Epub 2021 Apr 6.
6
Measuring Self-Reported Cancer-Related Cognitive Impairment: Recommendations From the Cancer Neuroscience Initiative Working Group.测量自我报告的癌症相关认知障碍:癌症神经科学倡议工作组的建议。
J Natl Cancer Inst. 2021 Nov 29;113(12):1625-1633. doi: 10.1093/jnci/djab027.
7
Epidemiology, Staging, and Management of Multiple Myeloma.多发性骨髓瘤的流行病学、分期和治疗。
Med Sci (Basel). 2021 Jan 20;9(1):3. doi: 10.3390/medsci9010003.
8
Geriatric assessment in older alloHCT recipients: association of functional and cognitive impairment with outcomes.老年异基因造血干细胞移植受者的老年评估:功能和认知障碍与预后的关联。
Blood Adv. 2020 Jun 23;4(12):2810-2820. doi: 10.1182/bloodadvances.2020001719.
9
Pretransplantation Cognitive Dysfunction in Advanced-Age Hematologic Cancers: Predictors and Associated Outcomes.老年血液系统恶性肿瘤患者移植前认知功能障碍:预测因素及相关结局
Biol Blood Marrow Transplant. 2020 Aug;26(8):1497-1504. doi: 10.1016/j.bbmt.2020.05.010. Epub 2020 May 21.
10
Minimally Important Differences for Interpreting EORTC QLQ-C30 Scores in Patients With Advanced Breast Cancer.晚期乳腺癌患者中用于解释欧洲癌症研究与治疗组织核心生活质量问卷C30评分的最小重要差异
JNCI Cancer Spectr. 2019 Jun 4;3(3):pkz037. doi: 10.1093/jncics/pkz037. eCollection 2019 Sep.